Adriana Trifan

Dr. Adriana Trifan

UMF Grigore T Popa Iasi, Iaşi, Romania
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2022 in Processes
Verified
Journal Article
Open access
PDF file
AJAlexandra Jitǎreanu
Alexandra Jitǎreanu
Adriana TrifanAdriana Trifan
Adriana Trifan
MVMadalina Vieriu
Madalina Vieriu
Ioana Cezara CabaIoana Cezara Caba
Ioana Cezara Caba
IMIoana Martu
Ioana Martu
LALuminița Agoroaei
Luminița Agoroaei
Even in modern times, the popularity level of medicinal plants and herbal medicines in therapy is still high. The World Health Organization estimates that 80% of the population in developing countries uses these types of remedies. Even though herbal medicine products are usually perceived as low risk, their potential health risks should be carefully assessed. Several factors can cause the toxicity of herbal medicine products: plant components or metabolites with a toxic potential, adulteration, environmental pollutants (heavy metals, pesticides), or contamination of microorganisms (toxigenic fungi). Their correct evaluation is essential for the patient’s safety. The toxicity assessment of herbal medicine combines in vitro and in vivo methods, but in the past decades, several new techniques emerged besides conventional methods. The use of omics has become a valuable research tool for prediction and toxicity evaluation, while DNA sequencing can be used successfully to detect contaminants and adulteration. The use of invertebrate models (Danio renio or Galleria mellonella) became popular due to the ethical issues associated with vertebrate models. The aim of the present article is to provide an overview of the current trends and methods used to investigate the toxic potential of herbal medicinal products and the challenges in this research field.

1 March 2021 in Processes
Verified
Journal Article
Open access
PDF file
CSCarine Sebaaly
Carine Sebaaly
Adriana TrifanAdriana Trifan
Adriana Trifan
Elwira SieniawskaElwira Sieniawska
Elwira Sieniawska
HGHelene Greige
Helene Greige
In recent years, liposomes have gained increasing attention for their potential applications as drug delivery systems in the pharmaceutic, cosmetic and food industries. However, they have a tendency to aggregate and are sensitive to degradation caused by several factors, which may limit their effectiveness. A promising approach to improve liposomal stability is to modify liposomal surfaces by forming polymeric layers. Among natural polymers, chitosan has received great interest due to its biocompatibility and biodegradability. This review discussed the characteristics of this combined system, called chitosomes, in comparison to those of conventional liposomes. The coating of liposomes with chitosan or its derivatives improved liposome stability, provided sustained drug release and increased drug penetration across mucus layers. The mechanisms behind these results are highlighted in this paper. Alternative assembly of polyelectrolytes using alginate, sodium hyaluronate, or pectin with chitosan could further improve the liposomal characteristics. Chitosomal encapsulation could also ensure targeted delivery and boost the antimicrobial efficacy of essential oils (EOs). Moreover, chitosomes could be an efficient tool to overcome the major drawbacks related to the chemical properties of EOs (low water solubility, sensitivity to oxygen, light, heat, and humidity) and their poor bioavailability. Overall, chitosomes could be considered as a promising strategy to enlarge the use of liposomes.

28 July 2016 in Medicines
Verified
Journal Article
Open access
PDF file
PAPetruta Aelenei
Petruta Aelenei
AMAnca Miron
Anca Miron
Adriana TrifanAdriana Trifan
Adriana Trifan
ABAlexandra Bujor
Alexandra Bujor
EGElvira Gille
Elvira Gille
AAAna Clara Aprotosoaie
Ana Clara Aprotosoaie
Gram-negative bacteria cause infections that are difficult to treat due to the emergence of multidrug resistance. This review summarizes the current status of the studies investigating the capacity of essential oils and their components to modulate antibiotic activity against Gram-negative bacteria. Synergistic interactions are particularly discussed with reference to possible mechanisms by which essential oil constituents interact with antibiotics. Special emphasis is given to essential oils and volatile compounds that inhibit efflux pumps, thus reversing drug resistance in Gram-negative bacteria. In addition, indifference and antagonism between essential oils/volatile compounds and conventional antibiotics have also been reported. Overall, this literature review reveals that essential oils and their purified components enhance the efficacy of antibiotics against Gram-negative bacteria, being promising candidates for the development of new effective formulations against Gram-negative bacteria.

21 May 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
Adriana TrifanAdriana Trifan
Adriana Trifan
Gökhan ZenginGökhan Zengin
Gökhan Zengin
SISinan Kouadio Ibrahime
Sinan Kouadio Ibrahime
Elwira SieniawskaElwira Sieniawska
Elwira Sieniawska
RSRafal Sawicki
Rafal Sawicki
Simon Vlad LucaSimon Vlad Luca
Simon Vlad Luca
The Artemisia L. genus comprises over 500 species with important medicinal and economic attributes. Our study aimed at providing a comprehensive metabolite profiling and bioactivity assessment of five Artemisia species collected from northeastern Romania (A. absinthium L., A. annua L., A. austriaca Jacq., A. pontica L. and A. vulgaris L.). Liquid chromatography–tandem high-resolution mass spectrometry (LC-HRMS/MS) analysis of methanol and chloroform extracts obtained from the roots and aerial parts of the plants led to the identification of 15 phenolic acids (mostly hydroxycinnamic acid derivatives), 26 flavonoids (poly-hydroxylated/poly-methoxylated flavone derivatives, present only in the aerial parts), 14 sesquiterpene lactones, 3 coumarins, 1 lignan and 7 fatty acids. Clustered image map (CIM) analysis of the phytochemical profiles revealed that A. annua was similar to A. absinthium and that A. pontica was similar to A. austriaca, whereas A. vulgaris represented a cluster of its own. Correlated with their total phenolic contents, the methanol extracts from both parts of the plants showed the highest antioxidant effects, as assessed by the DPPH and ABTS radical scavenging, CUPRAC, FRAP and total antioxidant capacity methods. Artemisia extracts proved to be promising sources of enzyme inhibitory agents, with the methanol aerial part extracts being the most active samples against acetylcholinesterase and glucosidase. All Artemisia samples displayed good antibacterial effects against Mycobacterium tuberculosis H37Ra, with MIC values of 64–256 mg/L. In conclusion, the investigated Artemisia species proved to be rich sources of bioactives endowed with antioxidant, enzyme inhibitory and anti-mycobacterial properties.

17 December 2016 in Diseases
Verified
Journal Article
Open access
PDF file
AAAna Clara Aprotosoaie
Ana Clara Aprotosoaie
AMAnca Miron
Anca Miron
Adriana TrifanAdriana Trifan
Adriana Trifan
Simon Vlad LucaSimon Vlad Luca
Simon Vlad Luca
Irina Iuliana COSTACHE-ENACHEIrina Iuliana COSTACHE-ENACHE
Irina Iuliana COSTACHE-ENACHE
Cocoa is a rich source of high-quality antioxidant polyphenols. They comprise mainly catechins (29%–38% of total polyphenols), anthocyanins (4% of total polyphenols) and proanthocyanidins (58%–65% of total polyphenols). A growing body of experimental and epidemiological evidence highlights that the intake of cocoa polyphenols may reduce the risk of cardiovascular events. Beyond antioxidant properties, cocoa polyphenols exert blood pressure lowering activity, antiplatelet, anti-inflammatory, metabolic and anti-atherosclerotic effects, and also improve endothelial function. This paper reviews the role of cocoa polyphenols in cardiovascular protection, with a special focus on mechanisms of action, clinical relevance and correlation between antioxidant activity and cardiovascular health.

1 February 2018 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
Adriana TrifanAdriana Trifan
Adriana Trifan
SOSebastian E.W. Opitz
Sebastian E.W. Opitz
RJRoland Josuran
Roland Josuran
AGAndreas Grubelnik
Andreas Grubelnik
NENils Esslinger
Nils Esslinger
EWEvelyn Wolfram
Evelyn Wolfram